Skip To Main Content

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

Patients Factors & Impacts

Myeloma Facts

What is your experience with Dupixent in your practice?

Edition Junior Study - Helping patients with type 1 diabetes (T1D) to find better treatment options

Hear from an expert on how does Dupixent target Underlying Type 2 Inflammation?

Hear from an expert on would you consider a biologic for a Surgery-naïve Patient with CRS with Nasal Polyps?

Hear from an expert on Identifying Patients who are appropriate candidates for Biologic treatment

Type 2 Inflammation is the underlying cause of CRSwNP in 80% of Patients.

There is significant unmet need in the management of PN¹

Look beyond the symptoms to identify and manage Patients with Type 2 Inflammation

What gives you confidence that Dupixent improves patients’ quality of life?

Changing trends in VTE: Pulmonary Embolism cases on Rise within the Last Decade

Danish study finds more elderly and patients with comorbidities being diagnosed.